Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | General Counsel | September 14, 2026 | September 16, 2026 |
| Outset Medical, Inc.OM · Entity 7026 | General Counsel | August 17, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,000 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Grant · Acquired 29,000 · Balance 29,000 F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.99 · Expires 2036-09-13 | Direct | 85,000 |
Reported balance
After 2026-09-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-14 · Grant · Acquired 85,000 · Balance 85,000 F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
F2: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
Outset Medical, Inc.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,475 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 2,632 · Balance 87,475 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 20:20 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $27.99 | $0.00 |
DisclosureSEC source: 0001823381-26-000014 · form4-09162026_080954.xml · derivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2036-09-13 F2 · derivative.exercise_date: One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| September 14, 2026 Filed Sep 16, 2026 20:20 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | GrantCommon Stock | 29,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001823381-26-000014 · form4-09162026_080954.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,000 F1 · kind: Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 22:51 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,632 | $4.39 | $11,554.48 |
DisclosureSEC source: 0001484612-26-000048 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,475 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:17 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 59,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-26-000045 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,107 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| May 15, 2026 Filed May 20, 2026 01:08 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,638 | $3.70 | $9,760.60 |
DisclosureSEC source: 0001484612-26-000025 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,277 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 2,842 shares instead of the correct number, 2,862 shares. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:57 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,842 | $3.35 | $9,520.70 |
DisclosureSEC source: 0001823381-26-000006 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,935 F1 · shares: Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 5,032 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2026 Filed Jan 22, 2026 00:05 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,180 | $5.01 | $5,911.80 |
DisclosureSEC source: 0001484612-26-000017 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,777 F1 · shares: Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 17,997 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 00:05 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 9,314 | $5.12 | $47,687.68 |
DisclosureSEC source: 0001484612-26-000017 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,957 F1 · shares: Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 17,997 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 22:09 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 224 | $4.27 | $956.48 |
DisclosureSEC source: 0001484612-26-000005 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,271 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 447 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:28 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 388 | $4.60 | $1,784.80 |
DisclosureSEC source: 0001484612-25-000078 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,495 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 20:00 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 383 | $12.88 | $4,933.04 |
DisclosureSEC source: 0001484612-25-000070 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,883 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:33 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 35,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000061 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,266 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on June 10, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 50% on January 17, 2026, and the remaining 50% shall vest in equal installments over the course of the following year on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| May 15, 2025 Filed May 16, 2025 21:21 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 396 | $17.82 | $7,056.72 |
DisclosureSEC source: 0001484612-25-000046 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,273 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 748 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,145 | $0.90 | $5,530.50 |
DisclosureSEC source: 0001484612-25-000031 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,043 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 11,934 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 6, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:03 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,679 | $0.80 | $2,143.20 |
DisclosureSEC source: 0001484612-25-000023 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,188 F4 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:03 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 29,474 | $0.80 | $23,579.20 |
DisclosureSEC source: 0001484612-25-000023 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,867 F3 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:03 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 777 | $0.80 | $621.60 |
DisclosureSEC source: 0001484612-25-000023 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,341 F2 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,318 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on January 26, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:03 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 9,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000023 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,118 F1 · shares: On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:34 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 20,492 | $0.81 | $16,598.52 |
DisclosureSEC source: 0001484612-25-000014 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,028 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,572 | $1.29 | $2,027.88 |
DisclosureSEC source: 0001484612-25-000006 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,520 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,530 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:45 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,203 | $0.80 | $2,562.40 |
DisclosureSEC source: 0001484612-24-000072 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,092 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,888 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 23:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,011 | $0.84 | $2,529.24 |
DisclosureSEC source: 0001484612-24-000064 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,295 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:17 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 10,569 | $4.78 | $50,519.82 |
DisclosureSEC source: 0001484612-24-000058 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,306 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $4.77 - $4.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:36 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,972 | $3.53 | $10,491.16 |
DisclosureSEC source: 0001484612-24-000047 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,875 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,341 | $3.57 | $11,927.37 |
DisclosureSEC source: 0001484612-24-000028 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,046 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,891 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,480 | $4.29 | $6,349.20 |
DisclosureSEC source: 0001484612-24-000015 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,387 F4 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (3) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 5,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000015 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,867 F3 · shares: On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000015 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,807 F2 · shares: Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:00 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 96,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000015 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,807 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 01:30 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 7,344 | $5.49 | $40,318.56 |
DisclosureSEC source: 0001484612-24-000008 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,807 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 12,944 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,431 | $4.76 | $6,811.56 |
DisclosureSEC source: 0001484612-23-000086 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,151 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,651 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 20:28 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,364 | $15.10 | $20,596.40 |
DisclosureSEC source: 0001484612-23-000068 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,581 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,652 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| July 19, 2023 Filed Jul 20, 2023 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,415 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-23-000054 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,560 Underlying: Common Stock · 1,415 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| July 19, 2023 Filed Jul 20, 2023 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,415 | $20.00 | $28,300.00 |
DisclosureSEC source: 0001484612-23-000054 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,945 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| July 19, 2023 Filed Jul 20, 2023 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,415 | $9.48 | $13,414.20 |
DisclosureSEC source: 0001484612-23-000054 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,414 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-23-000051 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,975 Underlying: Common Stock · 1,414 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,414 | $21.97 | $31,065.58 |
DisclosureSEC source: 0001484612-23-000051 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,945 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,414 | $9.48 | $13,404.72 |
DisclosureSEC source: 0001484612-23-000051 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2023 Filed May 17, 2023 22:26 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,415 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-23-000041 · edgardoc.xml · derivative · entry 5 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,389 Underlying: Common Stock · 1,415 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| May 17, 2023 Filed May 17, 2023 22:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,317 | $20.08 | $26,445.36 |
DisclosureSEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,945 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| May 17, 2023 Filed May 17, 2023 22:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,415 | $20.08 | $28,413.20 |
DisclosureSEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,262 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| May 17, 2023 Filed May 17, 2023 22:26 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,415 | $9.48 | $13,414.20 |
DisclosureSEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| May 16, 2023 Filed May 17, 2023 22:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,335 | $19.91 | $26,579.85 |
DisclosureSEC source: 0001484612-23-000041 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,262 F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| May 03, 2023 Filed May 5, 2023 22:13 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,414 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001484612-23-000033 · edgardoc.xml · derivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,804 Underlying: Common Stock · 1,414 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| May 03, 2023 Filed May 5, 2023 22:13 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,414 | $20.00 | $28,280.00 |
DisclosureSEC source: 0001484612-23-000033 · edgardoc.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,597 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| May 03, 2023 Filed May 5, 2023 22:13 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,414 | $9.48 | $13,404.72 |
DisclosureSEC source: 0001484612-23-000033 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:30 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,415 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001140361-23-012810 · form4.xml · derivative · entry 4 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,218 Underlying: Common Stock · 1,415 shares Expires 2030-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:30 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,715 | $20.82 | $56,526.30 |
DisclosureSEC source: 0001140361-23-012810 · form4.xml · nonDerivative · entry 3 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,597 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:30 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,415 | $20.82 | $29,460.30 |
DisclosureSEC source: 0001140361-23-012810 · form4.xml · nonDerivative · entry 2 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,312 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| March 20, 2023 Filed Mar 21, 2023 20:30 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,415 | $9.48 | $13,414.20 |
DisclosureSEC source: 0001140361-23-012810 · form4.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.